Serum TNF-α and IL-1β levels in patients with RNFL thinning in uveitis complicated by optic nerve inflammation

Purpose: To assess serum tumor necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) levels in patients with retinal nerve fiber layer (RNFL) thinning in uveitis complicated by optic nerve inflammation. Material and Methods: One hundred and thirty-two patients underwent examination and treatment....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oftalmologicheskiĭ zhurnal. 2020-12, Vol.89 (6), p.14-18
Hauptverfasser: Panchenko, M. V., Nikolaienko, M. M., Honchar, O. M., Prykhodko, D. O., Pereiaslova, H. S., Sokol, O. O.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose: To assess serum tumor necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) levels in patients with retinal nerve fiber layer (RNFL) thinning in uveitis complicated by optic nerve inflammation. Material and Methods: One hundred and thirty-two patients underwent examination and treatment. Serum TNF-α and IL-1β levels were determined by commercially available enzyme-linked immunoassay kits. Results: The serum TNF-α level was more than 1.5 times higher in patients with uveitis complicated by optic nerve inflammation who had reduced RNFL thickness compared to patients with normal RNFL thickness (p < 0.05), and the serum IL-1β level was 17% higher in the former patients than in the latter patients (p > 0.05). Conclusion: In the active stage of uveitis, the serum TNF-α level was significantly higher in patients with RNFL thinning due to uveitis complicated by optic nerve inflammation compared to patients with normal RNFL thickness, and the serum IL-1β level was higher in the former patients than in the latter patients, but the difference was not statistically significant. The results of the study may justify the use of biologic therapy in the treatment of uveitis complicated by optic nerve inflammation.
ISSN:0030-0675
2412-8740
DOI:10.31288/oftalmolzh202061418